![Diabetes Essentials 2011 - Iowa Dental Association](http://s1.studyres.com/store/data/000903856_1-9dfc815d6cf000822bb84e75a3a3452a-300x300.png)
Diabetes Essentials 2011 - Iowa Dental Association
... Learning Objectives • Appreciate the challenge of diabetes from the patient’s perspective • Differentiate type 1 from type 2 • Understand insulin action • Understand complications of diabetes • Know the major classes of medications • Know the side effects of each class • Recognize hypoglycemia as a ...
... Learning Objectives • Appreciate the challenge of diabetes from the patient’s perspective • Differentiate type 1 from type 2 • Understand insulin action • Understand complications of diabetes • Know the major classes of medications • Know the side effects of each class • Recognize hypoglycemia as a ...
cms/lib/NY01001456/Centricity/Domain/535/Endocrine System
... 9. What is the function of the TSH (thyroidstimulating hormone)? Stimulates the thyroid gland to secrete its hormone 10. What is the function of the FSH (follicle-stimulating hormone)? stimulates sperm production; stimulates egg production and estrogen secretion ...
... 9. What is the function of the TSH (thyroidstimulating hormone)? Stimulates the thyroid gland to secrete its hormone 10. What is the function of the FSH (follicle-stimulating hormone)? stimulates sperm production; stimulates egg production and estrogen secretion ...
Nervous and Endocrine System
... potential. When a stimulus is detected, the cell membrane is excited and become more permeable, allowing more ions to move in and out of the cell – altering the potential difference. The change in potential difference due to a stimulus is called the generator potential. ...
... potential. When a stimulus is detected, the cell membrane is excited and become more permeable, allowing more ions to move in and out of the cell – altering the potential difference. The change in potential difference due to a stimulus is called the generator potential. ...
Diabetes treatment
... Multiple Dose Injection (MDI) therapy for about 5 years. She is currently prescribed glargine insulin (Lantus®) 15u at 10 PM and ...
... Multiple Dose Injection (MDI) therapy for about 5 years. She is currently prescribed glargine insulin (Lantus®) 15u at 10 PM and ...
Endocrine system
... In type 1 diabetes, the body does not produce insulin, a hormone that is needed for cells to uptake glucose. Symptoms include increased thirst, weight loss, fatigue, blurred vision. Only 5% of people with diabetes have this form of the disease. Treatment: ...
... In type 1 diabetes, the body does not produce insulin, a hormone that is needed for cells to uptake glucose. Symptoms include increased thirst, weight loss, fatigue, blurred vision. Only 5% of people with diabetes have this form of the disease. Treatment: ...
O`Kane
... C. helps enhance (increase) appetite. D. gets released from adipocytes when lipids are absorbed. 9. Endocrine secretions are released into the _______________ whereas exocrine secretions are released into the ________________. A. external environment; external environment B. bloodstream; bloodstream ...
... C. helps enhance (increase) appetite. D. gets released from adipocytes when lipids are absorbed. 9. Endocrine secretions are released into the _______________ whereas exocrine secretions are released into the ________________. A. external environment; external environment B. bloodstream; bloodstream ...
My Pediatric Endocrine Powerpoint
... Insulin facilitates entry of glucose/K+ into the cell. Too little insulin… * body in a state of starvation causing hunger (polyphagia) * concentration of glucose increases in the blood stream * when glucose exceeds the renal threshold, glycosuria occurs * this in turn causes osmotic diversion of wat ...
... Insulin facilitates entry of glucose/K+ into the cell. Too little insulin… * body in a state of starvation causing hunger (polyphagia) * concentration of glucose increases in the blood stream * when glucose exceeds the renal threshold, glycosuria occurs * this in turn causes osmotic diversion of wat ...
Chapter 36 Insulin and oral hypoglycemic agents
... • Liver cells store glycogen only up to 5-6% – Remaining glucose metabolized to fat – Triglycerides are synthesized and release into blood – Inhibits breakdown of fatty acids to ketones. ...
... • Liver cells store glycogen only up to 5-6% – Remaining glucose metabolized to fat – Triglycerides are synthesized and release into blood – Inhibits breakdown of fatty acids to ketones. ...
Endocrine
... Insulin Dependent Diabetes Mellitus Type I - IDDM Juvenile Onset • Genetic Predisposition or virus – causes an autoimmune process – destroys pancreatic insulin secreting B cells • ↓↓↓ Insulin Production – Glucose unable to enter the cells = Hyperglycemia – Glucose unavailable for cell metabolism = ...
... Insulin Dependent Diabetes Mellitus Type I - IDDM Juvenile Onset • Genetic Predisposition or virus – causes an autoimmune process – destroys pancreatic insulin secreting B cells • ↓↓↓ Insulin Production – Glucose unable to enter the cells = Hyperglycemia – Glucose unavailable for cell metabolism = ...
Name the hormone responsible for the
... Thyroid Profile: TSH levels slightly increased Bound T4: Normal Bound T3: Normal Urine test: RBC: None Pus cells: None Glucose: Present Ketone Bodies: Present Urea: Increase Which is the most likely diagnosis: a. Hypothyroidism b. Hyperthyroidism c. Hyperinsulinemia d. Hypoinsulinemia e. Ketoacidosi ...
... Thyroid Profile: TSH levels slightly increased Bound T4: Normal Bound T3: Normal Urine test: RBC: None Pus cells: None Glucose: Present Ketone Bodies: Present Urea: Increase Which is the most likely diagnosis: a. Hypothyroidism b. Hyperthyroidism c. Hyperinsulinemia d. Hypoinsulinemia e. Ketoacidosi ...
PROBLEM BASED LEARNING
... What arte the major abnormalities in the investigation results and what do these indicate ? • The patient has very high blood glucose levels with elevated ketone levels in plasma and urine. This would indicate Diabetes mellitus and also Ketosis (excess ketone production) which is commonly seen with ...
... What arte the major abnormalities in the investigation results and what do these indicate ? • The patient has very high blood glucose levels with elevated ketone levels in plasma and urine. This would indicate Diabetes mellitus and also Ketosis (excess ketone production) which is commonly seen with ...
Insulin and drugs us..
... The rationale for the α-glucosidase inhibitors is that by preventing the hydrolysis of carbohydrate their absorption could be reduced. The oligosaccharidases responsible for final hydrolysis of these materials are all located in the brush border of the small intestine and consist of two classes: ...
... The rationale for the α-glucosidase inhibitors is that by preventing the hydrolysis of carbohydrate their absorption could be reduced. The oligosaccharidases responsible for final hydrolysis of these materials are all located in the brush border of the small intestine and consist of two classes: ...
ap biology ch - Birdville ISD
... Calcitonin vs. PTH (parathyroid hormone) -Ca2+ regulation…calcitonin lowers blood concentration of Ca2+, PTH raises it…. -low vitamin D = rickets, low vitamin C = scurvy ...
... Calcitonin vs. PTH (parathyroid hormone) -Ca2+ regulation…calcitonin lowers blood concentration of Ca2+, PTH raises it…. -low vitamin D = rickets, low vitamin C = scurvy ...
Diabetes • Hormones of the Pancreas o Alpha Cells – glucagon
... o Action is to increase insulin sensitivity at the tissue/cellular level. Enhances insulin action without stimulating insulin secretion o Monotherapy or adjunctive therapy o Average decrease in HbA1c approx 0.7 -2.5% o May cause weight gain o Monitor liver function o Questions Name two thiazolided ...
... o Action is to increase insulin sensitivity at the tissue/cellular level. Enhances insulin action without stimulating insulin secretion o Monotherapy or adjunctive therapy o Average decrease in HbA1c approx 0.7 -2.5% o May cause weight gain o Monitor liver function o Questions Name two thiazolided ...
Chapter 1
... diabetes, and discusses previous IVGTT, and OGTT models. Chapter 4 discusses recent understandings of the body’s insulin production and release mechanism. The pancreas, shown in figure 1.1.1, is located near to the stomach produces insulin, and delivers it directly to the portal vein. ...
... diabetes, and discusses previous IVGTT, and OGTT models. Chapter 4 discusses recent understandings of the body’s insulin production and release mechanism. The pancreas, shown in figure 1.1.1, is located near to the stomach produces insulin, and delivers it directly to the portal vein. ...
Diabetes: Type 2
... Most people are overweight at the time their Type 2 diabetes is discovered. Being more active or losing weight may help prevent or delay the development of diabetes. Type 2 diabetes was once called "Adult-onset Diabetes" but this term is no longer used because it is inaccurate. Type 2 diabetes is on ...
... Most people are overweight at the time their Type 2 diabetes is discovered. Being more active or losing weight may help prevent or delay the development of diabetes. Type 2 diabetes was once called "Adult-onset Diabetes" but this term is no longer used because it is inaccurate. Type 2 diabetes is on ...
The yeast Saccharomyces cerevisiae uses a permease
... Incretin Action as the Basis for the Treatment of Type 2 Diabetes ...
... Incretin Action as the Basis for the Treatment of Type 2 Diabetes ...
Pituitary Agents. Thyroid and Antithyroid Agents. Antidiabe
... • Alpha Cells – Produce glucagon and raise blood glucose levels ...
... • Alpha Cells – Produce glucagon and raise blood glucose levels ...
Sickle Cell Disease
... glucose into cells throughout the body. If no insulin can be produced, the glucose stays in the blood instead, where it can cause serious damage to all the organ systems of the body. ...
... glucose into cells throughout the body. If no insulin can be produced, the glucose stays in the blood instead, where it can cause serious damage to all the organ systems of the body. ...
Insulin Secretory and Insulin Resistance Defects in Type 2 Diabetes
... In recent decades, the number of people in the United States and throughout the developed world affected by type 2 DM has steadily climbed to the point of an epidemic, placing a staggering clinical and economic burden on modern society. The estimated worldwide prevalence of type 2 DM in 2001 was 150 ...
... In recent decades, the number of people in the United States and throughout the developed world affected by type 2 DM has steadily climbed to the point of an epidemic, placing a staggering clinical and economic burden on modern society. The estimated worldwide prevalence of type 2 DM in 2001 was 150 ...
Managing Diabetes in Primary Care in the Caribbean
... If the first test is normal, retest high-risk patients at 24-28 weeks gestation. Diagnostic Criteria There are two main glucose tolerance tests used for diagnosing gestational diabetes. The test using 100 g glucose is also widely used for detection of ‘at risk’ infants and mothers. ...
... If the first test is normal, retest high-risk patients at 24-28 weeks gestation. Diagnostic Criteria There are two main glucose tolerance tests used for diagnosing gestational diabetes. The test using 100 g glucose is also widely used for detection of ‘at risk’ infants and mothers. ...
Artificial pancreas
The artificial pancreas is a technology in development to help people with diabetes automatically control their blood glucose level by providing the substitute endocrine functionality of a healthy pancreas.There are several important exocrine (digestive) and endocrine (hormonal) functions of the pancreas, but it is the lack of insulin production which is the motivation to develop a substitute. While the current state of insulin replacement therapy is appreciated for its life-saving capability, the task of manually managing the blood sugar level with insulin alone is arduous and inadequate.The goal of the artificial pancreas is two-fold:to improve insulin replacement therapy until glycemic control is practically normal as evident by the avoidance of the complications of hyperglycemia, and to ease the burden of therapy for the insulin-dependent.Different approaches under consideration include: the medical equipment approach—using an insulin pump under closed loop control using real-time data from a continuous blood glucose sensor. the bioengineering approach—the development of a bio-artificial pancreas consisting of a biocompatible sheet of encapsulated beta cells. When surgically implanted, the islet sheet will behave as the endocrine pancreas and will be viable for years. the gene therapy approach—the therapeutic infection of a diabetic person by a genetically engineered virus which causes a DNA change of intestinal cells to become insulin-producing cells.